Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company PEP-Therapy S.A.S.
DescriptionA linear peptide comprising DPT, a shuttle to deliver the peptide into the cell, and PEP3, an interfering peptide targeting the Hippo signaling pathway
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today